What is Regenxbio's EV / sales?

Regenxbio (RGNX) reported EV / sales of 5.6× in Q1 2026.

How has Regenxbio's EV / sales changed year-over-year?

Regenxbio's EV / sales increased by 183.1% year-over-year, from 2× to 5.6×.

What is the long-term trend for Regenxbio's EV / sales?

Over 5 years (2020 to 2025), Regenxbio's EV / sales has grown at a -16.1% compound annual growth rate (CAGR), from 10.8× to 4.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Regenxbio RGNX EV / sales

EV / sales at other companies

Regeneron PharmaceuticalsREGN

5.5×+0.6×

Sarepta Therapeutics, Inc.SRPT

0.9×—

BiogenBIIB

3×+0.8×

BioMarin PharmaceuticalsBMRN

2.8×-1.6×

EyePoint, Inc. EYPT

134×+128×

Ultragenyx PharmaceuticalRARE

2.7×-4.0×

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Calculated from Regenxbio’s reported figures.

enterprise value/total revenue=5.6×

Based on the most recent quarter.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's EV / sales?: Regenxbio (RGNX) reported EV / sales of 5.6× in Q1 2026.
How has Regenxbio's EV / sales changed year-over-year?: Regenxbio's EV / sales increased by 183.1% year-over-year, from 2× to 5.6×.
What is the long-term trend for Regenxbio's EV / sales?: Over 5 years (2020 to 2025), Regenxbio's EV / sales has grown at a -16.1% compound annual growth rate (CAGR), from 10.8× to 4.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.